Back to Search
Start Over
Supplementary Table 1 from A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 1 - PDF file 74K, Mean (SD) pharmacokinetic parameters of IPI-504 and metabolites on Cycle 1, Day 1
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....f7dbad7695bec95e9a2a536bccd44fa7
- Full Text :
- https://doi.org/10.1158/1078-0432.22449941